BACE1 and Alzheimer disease: Electroporation-mediated loading of these CNS-targeted exosomes with siRNA to BACE1, a therapeutic target in AD, resulted in knockdown of BACE1 mRNA (60%) and protein (62%) in the brain of mice [132].